{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:02:40Z","timestamp":1784952160936,"version":"3.55.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["5-2021-A0094-00129"],"award-info":[{"award-number":["5-2021-A0094-00129"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI21C0940"],"award-info":[{"award-number":["HI21C0940"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Evaluation of genetic mutations in cancers is important because distinct mutational profiles help determine individualized drug therapy. However, molecular analyses are not routinely performed in all cancers because they are expensive, time-consuming and not universally available. Artificial intelligence (AI) has shown the potential to determine a wide range of genetic mutations on histologic image analysis. Here, we assessed the status of mutation prediction AI models on histologic images by a systematic review.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A literature search using the MEDLINE, Embase and Cochrane databases was conducted in August 2021. The articles were shortlisted by titles and abstracts. After a full-text review, publication trends, study characteristic analysis and comparison of performance metrics were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-four studies were found mostly from developed countries, and their number is increasing. The major targets were gastrointestinal, genitourinary, gynecological, lung and head and neck cancers. Most studies used the Cancer Genome Atlas, with a few using an in-house dataset. The area under the curve of some of the cancer driver gene mutations in particular organs was satisfactory, such as 0.92 of BRAF in thyroid cancers and 0.79 of EGFR in lung cancers, whereas the average of all gene mutations was 0.64, which is still suboptimal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>AI has the potential to predict gene mutations on histologic images with appropriate caution. Further validation with larger datasets is still required before AI models can be used in clinical practice to predict gene mutations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bib\/bbad151","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T10:36:22Z","timestamp":1682678182000},"source":"Crossref","is-referenced-by-count":24,"title":["Recent application of artificial intelligence on histopathologic image-based prediction of gene mutation in solid cancers"],"prefix":"10.1093","volume":"24","author":[{"given":"Mohammad Rizwan","family":"Alam","sequence":"first","affiliation":[{"name":"Department of Hospital Pathology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Jin","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Hospital Pathology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Abdul-Ghafar","sequence":"additional","affiliation":[{"name":"Department of Hospital Pathology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangil","family":"Yim","sequence":"additional","affiliation":[{"name":"Department of Hospital Pathology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hak","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hospital Pathology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jong","family":"Jang","sequence":"additional","affiliation":[{"name":"Catholic Big Data Integration Center, Department of Physiology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Kwon","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Hospital Pathology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosep","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Hospital Pathology, College of Medicine, The Catholic University of Korea , Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"2023121915415134800_ref1","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","article-title":"BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives","volume":"28","author":"Sanz-Garcia","year":"2017","journal-title":"Ann Oncol"},{"key":"2023121915415134800_ref2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2015.63.9674","article-title":"Extended RAS gene mutation testing in metastatic colorectal carcinoma to predict response to anti\u2013epidermal growth factor receptor monoclonal antibody therapy: American Society of Clinical Oncology provisional clinical opinion update 2015","volume":"34","author":"Allegra","year":"2016","journal-title":"J Clin Oncol"},{"key":"2023121915415134800_ref3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ejhg.2011.53","article-title":"Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies","volume":"19","author":"Schully","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"2023121915415134800_ref4","doi-asserted-by":"crossref","DOI":"10.1016\/S0011-3840(01)70035-4","article-title":"Hereditary breast cancer","volume":"38","author":"Robson","year":"2001","journal-title":"Curr Probl Surg"},{"key":"2023121915415134800_ref5","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1101\/gad.1593107","article-title":"The genetics of hereditary colon cancer","volume":"21","author":"Rustgi","year":"2007","journal-title":"Genes Dev"},{"key":"2023121915415134800_ref6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2012.46.8934","article-title":"Genomics-driven oncology: framework for an emerging paradigm","volume":"31","author":"Garraway","year":"2013","journal-title":"J Clin Oncol"},{"key":"2023121915415134800_ref7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.6004\/jnccn.2017.0036","article-title":"Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Benson","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"2023121915415134800_ref8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMc1510353","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"373","author":"Diaz","year":"2015","journal-title":"N Engl J Med"},{"key":"2023121915415134800_ref9","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/j.breast.2013.07.029","article-title":"Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies","volume":"22","author":"Pinto","year":"2013","journal-title":"Breast"},{"key":"2023121915415134800_ref10","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Lievre","year":"2006","journal-title":"Cancer Res"},{"key":"2023121915415134800_ref11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nbt1486","article-title":"Next-generation DNA sequencing","volume":"26","author":"Shendure","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2023121915415134800_ref12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"2023121915415134800_ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2018.02.010","article-title":"Genomics and emerging biomarkers for immunotherapy of colorectal cancer","volume":"52","author":"Kather","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"2023121915415134800_ref14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.gendis.2019.10.013","article-title":"Molecular subtypes of colorectal cancer: an emerging therapeutic opportunity for personalized medicine","volume":"8","author":"Singh","year":"2021","journal-title":"Genes Dis"},{"key":"2023121915415134800_ref15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer","volume":"25","author":"Kather","year":"2019","journal-title":"Nat Med"},{"key":"2023121915415134800_ref16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/modpathol.2017.104","article-title":"Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine","volume":"31","author":"Cheng","year":"2018","journal-title":"Mod Pathol"},{"key":"2023121915415134800_ref17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555-2738","article-title":"Evaluation of a rapid, fully automated platform for detection of BRAF and NRAS mutations in melanoma","volume":"98","author":"Barel","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"2023121915415134800_ref18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/CMR.0000000000000421","article-title":"Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, droplet digital PCR, and the Idylla mutation platform","volume":"28","author":"Bisschop","year":"2018","journal-title":"Melanoma Res"},{"key":"2023121915415134800_ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21896-9","article-title":"Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes","volume":"12","author":"Diao","year":"2021","journal-title":"Nat Commun"},{"key":"2023121915415134800_ref20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2019-319866","article-title":"Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning","volume":"70","author":"Sirinukunwattana","year":"2021","journal-title":"Gut"},{"key":"2023121915415134800_ref21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(19)32998-8","article-title":"Deep learning for prediction of colorectal cancer outcome: a discovery and validation study","volume":"395","author":"Skrede","year":"2020","journal-title":"Lancet"},{"key":"2023121915415134800_ref22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4132\/jptm.2020.08.27","article-title":"Recommendations for pathologic practice using digital pathology: consensus report of the Korean Society of Pathologists","volume":"54","author":"Chong","year":"2020","journal-title":"J Pathol Transl Med"},{"key":"2023121915415134800_ref23","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3390\/cancers14112590","article-title":"Recent applications of artificial intelligence from histopathologic image-based prediction of microsatellite instability in solid cancers: a systematic review","volume":"14","author":"Alam","year":"2022","journal-title":"Cancer"},{"key":"2023121915415134800_ref24","first-page":"1","article-title":"Deep learning-based histopathological segmentation for whole slide images of colorectal cancer in a compressed domain","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"2023121915415134800_ref25","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.3390\/cancers14143529","article-title":"Recent application of artificial intelligence in non-gynecological cancer cytopathology: a systematic review","volume":"14","author":"Thakur","year":"2022","journal-title":"Cancer"},{"key":"2023121915415134800_ref26","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/cancers14102400","article-title":"Current trend of artificial intelligence patents in digital pathology: a systematic evaluation of the patent landscape","volume":"14","author":"Ailia","year":"2022","journal-title":"Cancer"},{"key":"2023121915415134800_ref27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4132\/jptm.2019.12.31","article-title":"Introduction to digital pathology and computer-aided pathology","volume":"54","author":"Nam","year":"2020","journal-title":"J Pathol Transl Med"},{"key":"2023121915415134800_ref28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s43018-020-0087-6","article-title":"Pan-cancer image-based detection of clinically actionable genetic alterations","volume":"1","author":"Kather","year":"2020","journal-title":"Nat Cancer"},{"key":"2023121915415134800_ref29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s43018-020-0085-8","article-title":"Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis","volume":"1","author":"Fu","year":"2020","journal-title":"Nat Cancer"},{"key":"2023121915415134800_ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20030-5","article-title":"Deep learning-based cross-classifications reveal conserved spatial behaviors within tumor histological images","volume":"11","author":"Noorbakhsh","year":"2020","journal-title":"Nat Commun"},{"key":"2023121915415134800_ref31","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","article-title":"Classification and mutation prediction from non\u2013small cell lung cancer histopathology images using deep learning","volume":"24","author":"Coudray","year":"2018","journal-title":"Nat Med"},{"key":"2023121915415134800_ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-021-01081-8","article-title":"Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation","volume":"16","author":"Chong","year":"2021","journal-title":"Diagn Pathol"},{"key":"2023121915415134800_ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3926498","article-title":"Identification of \u201cbraf-positive\u201d cases based on whole-slide image analysis","volume":"2017","author":"Popovici","year":"2017","journal-title":"Biomed Res Int"},{"key":"2023121915415134800_ref34","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.3748\/wjg.v26.i40.6207","article-title":"Prediction of clinically actionable genetic alterations from colorectal cancer histopathology images using deep learning","volume":"26","author":"Jang","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2023121915415134800_ref35","doi-asserted-by":"crossref","DOI":"10.1101\/2021.01.19.21250122","article-title":"Novel deep learning algorithm predicts the status of molecular pathways and key mutations in colorectal cancer from routine histology images","volume-title":"medRxiv","author":"Bilal","year":"2021"},{"key":"2023121915415134800_ref36","first-page":"1","article-title":"Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning","volume":"4","author":"Chen","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"2023121915415134800_ref37","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.102","article-title":"Deep learning-based classification and mutation prediction from histopathological images of hepatocellular carcinoma","volume":"10","author":"Liao","year":"2020","journal-title":"Clin Transl Med"},{"key":"2023121915415134800_ref38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","article-title":"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial","volume":"28","author":"Roth","year":"2010","journal-title":"J Clin Oncol"},{"key":"2023121915415134800_ref39","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1158\/1078-0432.CCR-09-0741","article-title":"Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment TrialTissue biomarker development in colorectal cancer","volume":"15","author":"Bosman","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2023121915415134800_ref40","first-page":"e42001","article-title":"A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations","volume-title":"PLos One","author":"Xie","year":"2012"},{"key":"2023121915415134800_ref41","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2011.39.5814","article-title":"Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer","volume":"30","author":"Popovici","year":"2012","journal-title":"J Clin Oncol"},{"key":"2023121915415134800_ref42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.euf.2021.04.007","article-title":"Artificial intelligence\u2013based detection of FGFR3 mutational status directly from routine histology in bladder cancer: a possible preselection for molecular testing?","volume":"8","author":"Loeffler","year":"2022","journal-title":"Eur Urol Focus"},{"key":"2023121915415134800_ref43","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1002\/cam4.4044","article-title":"Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images","volume":"10","author":"Velmahos","year":"2021","journal-title":"Cancer Med"},{"key":"2023121915415134800_ref44","article-title":"H&E-stained whole slide image deep learning predicts SPOP mutation state in prostate cancer","author":"Schaumberg","year":"2018","journal-title":"BioRxiv"},{"key":"2023121915415134800_ref45","article-title":"Prediction of BRCA gene mutation in breast cancer based on deep learning and histopathology images","volume":"12","author":"Wang","year":"2021","journal-title":"Front Genet"},{"key":"2023121915415134800_ref46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ygyno.2021.07.015","article-title":"Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer","volume":"163","author":"Zeng","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2023121915415134800_ref47","article-title":"Identification and validation of efficacy of immunological therapy for lung cancer from histopathological images based on deep learning","volume":"12","author":"Yang","year":"2021","journal-title":"Front Genet"},{"key":"2023121915415134800_ref48","article-title":"Prediction of target-drug therapy by identifying gene mutations in lung cancer with histopathological stained image and deep learning techniques","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"2023121915415134800_ref49","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/jcm8101675","article-title":"Mapping driver mutations to histopathological subtypes in papillary thyroid carcinoma: applying a deep convolutional neural network","volume":"8","author":"Tsou","year":"2019","journal-title":"J Clin Med"},{"key":"2023121915415134800_ref50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.5773","article-title":"Weakly supervised learning on unannotated H&E-stained slides predicts BRAF mutation in thyroid cancer with high accuracy","volume":"255","author":"Anand","year":"2021","journal-title":"J Pathol"},{"key":"2023121915415134800_ref51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1145\/3445815.3445840","volume-title":"2020 4th International Conference on Computer Science and Artificial Intelligence","author":"Wu","year":"2020"},{"key":"2023121915415134800_ref52","doi-asserted-by":"crossref","DOI":"10.1101\/2021.09.16.21263694","article-title":"Prediction of BAP1 mutations in uveal melanoma patients from histology images using weakly supervised deep learning-based whole slide image analysis","volume-title":"medRxiv","author":"Mehdiratta","year":"2021"},{"key":"2023121915415134800_ref53","first-page":"1","article-title":"Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"2023121915415134800_ref54","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1089\/cmb.2019.0410","article-title":"A multiple-instance learning-based convolutional neural network model to detect the IDH1 mutation in the histopathology images of glioma tissues","volume":"27","author":"Cui","year":"2020","journal-title":"J Comput Biol"},{"key":"2023121915415134800_ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-95948-x","article-title":"Predicting prognosis and IDH mutation status for patients with lower-grade gliomas using whole slide images","volume":"11","author":"Jiang","year":"2021","journal-title":"Sci Rep"},{"key":"2023121915415134800_ref56","article-title":"A deep learning approach for rapid mutational screening in melanoma","author":"Kim","year":"2020","journal-title":"BioRxiv"},{"key":"2023121915415134800_ref57","first-page":"239","article-title":"Artificial intelligence and machine learning in oncology: historical overview of documents indexed in the web of science database","volume":"5","author":"Musa","year":"2021","journal-title":"EJMO"},{"key":"2023121915415134800_ref58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/jcm8030360","article-title":"Global evolution of research in artificial intelligence in health and medicine: a bibliometric study","volume":"8","author":"Tran","year":"2019","journal-title":"J Clin Med"},{"key":"2023121915415134800_ref59","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cancers12071884","article-title":"Current trends of artificial intelligence for colorectal cancer pathology image analysis: a systematic review","volume":"12","author":"Thakur","year":"2020","journal-title":"Cancer"},{"key":"2023121915415134800_ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41746-020-00324-0","article-title":"The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database","volume":"3","author":"Benjamens","year":"2020","journal-title":"NPJ Digit Med"},{"key":"2023121915415134800_ref61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000478-200305000-00001","article-title":"Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability","volume":"27","author":"Greenson","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2023121915415134800_ref62","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U","article-title":"Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma","volume":"91","author":"Smyrk","year":"2001","journal-title":"Cancer"},{"key":"2023121915415134800_ref63","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"2023121915415134800_ref64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pas.0000213351.49767.0f","article-title":"BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays","volume":"31","author":"Bane","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2023121915415134800_ref65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"2023121915415134800_ref66","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1200\/JCO.2015.61.4016","article-title":"BRAF mutation and thyroid cancer recurrence","volume":"33","author":"Xing","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2023121915415134800_ref67","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/cancers11091388","article-title":"BRAF inhibitors in thyroid cancer: clinical impact, mechanisms of resistance and future perspectives","volume":"11","author":"Crispo","year":"2019","journal-title":"Cancer"},{"key":"2023121915415134800_ref68","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1089\/thy.2019.0514","article-title":"Acquired secondary RAS mutation in BRAFV600E-mutated thyroid cancer patients treated with BRAF inhibitors","volume":"30","author":"Cabanillas","year":"2020","journal-title":"Thyroid"},{"key":"2023121915415134800_ref69","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.CCR-14-2915","article-title":"Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with DabrafenibDabrafenib stimulates radioiodine uptake in thyroid cancer","volume":"21","author":"Rothenberg","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2023121915415134800_ref70","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.3892\/ol.2016.4233","article-title":"Association between the histological subtype of lung adenocarcinoma, EGFR\/KRAS mutation status and the ALK rearrangement according to the novel IASLC\/ATS\/ERS classification","volume":"11","author":"Dong","year":"2016","journal-title":"Oncol Lett"},{"key":"2023121915415134800_ref71","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/j.cllc.2019.12.003","article-title":"Tyrosine kinase inhibitors for the treatment of EGFR mutation-positive non\u2013small-cell lung cancer: a clash of the generations","volume":"21","author":"Shah","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"2023121915415134800_ref72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cllc.2021.10.009","article-title":"Overall treatment strategy for patients with metastatic NSCLC with activating EGFR mutations","volume":"2022","author":"Hayashi","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"2023121915415134800_ref73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7888\/juoeh.41.153","article-title":"Treatment of non-small cell lung cancer with EGFR-mutations","volume":"41","author":"Yoneda","year":"2019","journal-title":"J UOEH"},{"key":"2023121915415134800_ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-016-0251-8","article-title":"Second-and third-generation ALK inhibitors for non-small cell lung cancer","volume":"9","author":"Wu","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2023121915415134800_ref75","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1200\/JCO.2009.23.6661","article-title":"EML4-ALK: honing in on a new target in non\u2013small-cell lung cancer","volume":"27","author":"Horn","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2023121915415134800_ref76","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","article-title":"Clinical features and outcome of patients with non\u2013small-cell lung cancer who harbor EML4-ALK","volume":"27","author":"Shaw","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023121915415134800_ref77","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","volume":"368","author":"Shaw","year":"2013","journal-title":"N Engl J Med"},{"key":"2023121915415134800_ref78","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1158\/1078-0432.CCR-09-0802","article-title":"Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western PopulationLung adenocarcinoma with ALK rearrangements","volume":"15","author":"Rodig","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2023121915415134800_ref79","article-title":"Artificial intelligence\u2013powered prediction of ALK gene rearrangement in patients with non\u2013small-cell lung cancer","volume":"6","author":"Terada","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"2023121915415134800_ref80","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"key":"2023121915415134800_ref81","article-title":"CTNNB1 alternation is a potential biomarker for immunotherapy prognosis in patients with hepatocellular carcinoma","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"2023121915415134800_ref82","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-17-0342","article-title":"TTK inhibitors as a targeted therapy for CTNNB1 (\u03b2-catenin) mutant CancersCTNNB1-mutant status predicts TTK inhibitor sensitivity","volume":"16","author":"Zaman","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"2023121915415134800_ref83","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.omtn.2022.07.015","article-title":"miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models","volume":"29","author":"Callegari","year":"2022","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"2023121915415134800_ref84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.17998\/jlc.2022.03.18","article-title":"A clinical and pathological update on hepatocellular carcinoma","volume":"22","author":"Renne","year":"2022","journal-title":"J Liver Cancer"},{"key":"2023121915415134800_ref85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-04291-6","article-title":"ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis","volume":"12","author":"Shang","year":"2021","journal-title":"Cell Death Dis"},{"key":"2023121915415134800_ref86","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2017.10.007","article-title":"Arid1a has context-dependent oncogenic and tumor suppressor functions in liver cancer","volume":"32","author":"Sun","year":"2017","journal-title":"Cancer Cell"},{"key":"2023121915415134800_ref87","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.27198","article-title":"Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification","volume":"60","author":"Ahn","year":"2014","journal-title":"Hepatology"},{"key":"2023121915415134800_ref88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"2023121915415134800_ref89","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng.3547","article-title":"Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer","volume":"48","author":"Fujimoto","year":"2016","journal-title":"Nat Genet"},{"key":"2023121915415134800_ref90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"2023121915415134800_ref91","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","article-title":"Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep"},{"key":"2023121915415134800_ref92","doi-asserted-by":"crossref","DOI":"10.1101\/2022.03.31.486643","article-title":"TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effects","volume-title":"BioRxiv","author":"Ragu","year":"2022"},{"key":"2023121915415134800_ref93","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(11)61847-3","article-title":"Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial","volume":"379","author":"Baselga","year":"2012","journal-title":"Lancet"},{"key":"2023121915415134800_ref94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/cco.2017.06.11","article-title":"Isocitrate dehydrogenase mutation as a therapeutic target in gliomas","volume":"6","author":"Han","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"2023121915415134800_ref95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00401-020-02243-6","article-title":"Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis","volume":"141","author":"Suwala","year":"2021","journal-title":"Acta Neuropathol"},{"key":"2023121915415134800_ref96","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41379-021-00795-w","article-title":"IDH-mutant gliomas with additional class-defining molecular events","volume":"34","author":"Ahrendsen","year":"2021","journal-title":"Mod Pathol"},{"key":"2023121915415134800_ref97","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3389\/fonc.2021.630953","article-title":"Artificial intelligence can cut costs while maintaining accuracy in colorectal cancer genotyping","volume":"11","author":"Kacew","year":"2021","journal-title":"Front Oncol"},{"key":"2023121915415134800_ref98","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.825353","article-title":"Computational analysis of pathological image enables interpretable prediction for microsatellite instability","volume-title":"Front Oncol","author":"Zhu"},{"key":"2023121915415134800_ref99","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1053\/j.gastro.2020.06.021","article-title":"Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning","volume":"159","author":"Echle","year":"2020","journal-title":"Gastroenterology"},{"key":"2023121915415134800_ref100","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","article-title":"Clinical-grade computational pathology using weakly supervised deep learning on whole slide images","volume":"25","author":"Campanella","year":"2019","journal-title":"Nat Med"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/3\/bbad151\/54583599\/bbad151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/3\/bbad151\/54583599\/bbad151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T16:16:55Z","timestamp":1703002615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbad151\/7145908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5,19]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbad151","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,4,27]]},"article-number":"bbad151"}}